Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (9)
2023
-
Fundamental Aspects and Relevance of Components in Antihistamine Eye Drops
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 431-438
2021
-
Multicentre study: Reliability and repeatability of Scheimpflug system measurement in keratoconus
British Journal of Ophthalmology, Vol. 105, Núm. 1, pp. 22-26
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2013
-
Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition
BMC Medical Genetics, Vol. 14, Núm. 1
-
Novel molecular diagnostic system of limbal stem cell deficiency based on MUC5AC transcript detection in corneal epithelium by PCR-reverse dot blot
Investigative Ophthalmology and Visual Science, Vol. 54, Núm. 8, pp. 5643-5652
-
Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis
PLoS ONE, Vol. 8, Núm. 10
-
Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis
Mediators of Inflammation, Vol. 2013
2012
-
Comparative study of limbal stem cell deficiency diagnosis methods: Detection of MUC5AC mRNA and goblet cells in corneal epithelium
Ophthalmology, Vol. 119, Núm. 5, pp. 923-929
-
Treatment of refractory uveitis with adalimumab: A prospective multicenter study of 131 patients
Ophthalmology, Vol. 119, Núm. 8, pp. 1575-1581